These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 3196378

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Effects of prostacyclin and taprostene in splanchnic artery occlusion shock.
    VanAntwerp DR, Hedley LR, Spires DA, Strosberg AM, Johnson G, Lefer AM.
    Eicosanoids; 1991; 4(1):15-20. PubMed ID: 2059456
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B, Squadrito F, Bussolino F, Calapai G, Altavilla D, Ioculano M, Campo GM, Canale P, Caputi AP.
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
    Stubenitsky R, van der Weerd RW, Haitsma DB, Verdouw PD, Duncker DJ.
    Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
    [Abstract] [Full Text] [Related]

  • 50. Effect of oral administration of pimobendan in cats with heart failure.
    Gordon SG, Saunders AB, Roland RM, Winter RL, Drourr L, Achen SE, Hariu CD, Fries RC, Boggess MM, Miller MW.
    J Am Vet Med Assoc; 2012 Jul 01; 241(1):89-94. PubMed ID: 22720992
    [Abstract] [Full Text] [Related]

  • 51. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
    Aoki N, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1988 Jul 01; 10(7):413-8. PubMed ID: 3419244
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Beneficial effects of a neutral protease inhibitor in traumatic shock.
    Hock CE, Lefer AM.
    Pharmacol Res Commun; 1985 Mar 01; 17(3):217-26. PubMed ID: 4011646
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Inotropic agents with calcium-sensitizing properties: clinical and hemodynamic effects of pimobendan.
    Kubo SH.
    Coron Artery Dis; 1994 Feb 01; 5(2):119-26. PubMed ID: 8180743
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Use of pimobendan in 170 cats (2006-2010).
    Macgregor JM, Rush JE, Laste NJ, Malakoff RL, Cunningham SM, Aronow N, Hall DJ, Williams J, Price LL.
    J Vet Cardiol; 2011 Dec 01; 13(4):251-60. PubMed ID: 22030289
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.